Hearing that your AMH (anti-Müllerian hormone) is low can feel like a door closing. It's one of the most anxiety-inducing lab results in fertility medicine — and one of the most misunderstood.

Low AMH means fewer eggs, not poor-quality eggs. That distinction is critical, because it changes the entire treatment strategy. And when cost isn't an insurmountable barrier — as it often is in the United States — patients with diminished ovarian reserve (DOR) can pursue approaches that meaningfully improve their cumulative odds of success.

Understanding AMH and What It Actually Tells You

AMH is a hormone produced by small follicles in the ovaries. It's a marker of ovarian reserve — essentially, how many eggs remain available for recruitment in any given cycle. It is not a measure of egg quality.

AMH Level (ng/mL)InterpretationExpected Response to Stimulation
Over 3.0High reserveStrong response; OHSS risk to manage
1.0–3.0Normal reserveTypical response; standard protocols
0.5–1.0Low reserveReduced response; modified protocols recommended
Below 0.5Very low reserveMinimal response likely; consider alternatives

A 32-year-old with an AMH of 0.7 ng/mL may have fewer eggs than average for her age, but the eggs she does produce are likely to be chromosomally normal at rates consistent with her age group. That's a fundamentally different prognosis than a 42-year-old with the same AMH level.

The Number That Matters More

While AMH tells you about quantity, your age tells you about quality. A younger patient with low AMH often has good per-egg success rates — she just needs a strategy to accumulate enough eggs or embryos over multiple cycles.

Modified IVF Protocols for Low AMH

Standard IVF protocols are designed for patients with normal or high ovarian reserve. For DOR patients, experienced reproductive endocrinologists modify the approach:

High-Dose Stimulation

Increasing gonadotropin dosing (FSH/LH medications) to maximize follicular recruitment from a smaller pool. Colombian fertility specialists routinely adjust protocols to the upper end of safe dosing ranges, monitoring closely via serial ultrasound and bloodwork.

Dual Stimulation (DuoStim)

Performing two stimulation cycles in a single menstrual month — one in the follicular phase and one in the luteal phase. This approach, pioneered by leading fertility centers worldwide, can double the number of eggs retrieved per calendar month. It's particularly valuable for patients with time pressure (age, planned cancer treatment).

Mini-IVF (Minimal Stimulation)

Counterintuitively, some DOR patients respond better to lower medication doses. Mini-IVF uses oral medications (clomiphene or letrozole) with low-dose injectables, aiming for 2–5 eggs rather than 10+. The theory: quality of the microenvironment around each follicle may improve with gentler stimulation.

Mini-IVF cycles in Colombia typically cost $1,500–$3,000 — making it feasible to pursue multiple cycles as an egg accumulation strategy.

Natural Cycle IVF

For patients who consistently produce only 1–2 follicles regardless of medication dose, natural cycle IVF eliminates stimulation medications entirely. The clinic monitors your natural cycle, retrieves the single egg your body selects, and proceeds with fertilization and transfer. At $1,500–$2,500 per cycle in Colombia, serial natural cycles become a realistic option.

The Accumulation Strategy

This is where Colombia's pricing transforms the clinical picture for DOR patients.

In the United States, each IVF cycle costs $15,000–$25,000. A patient with low AMH who retrieves 2–3 eggs per cycle might need 3–4 cycles to accumulate enough embryos for PGT-A screening and transfer. That's $45,000–$100,000 — prohibitive for most families.

In Colombia, the same accumulation strategy costs a fraction of that:

$5K–$8K
Per IVF cycle in Colombia
$15K–$24K
3 cycles accumulated
$45K–$75K
Same 3 cycles in the US

Three cycles in Colombia cost roughly the same as one cycle in the United States. This makes accumulation — banking eggs or embryos across multiple retrieval cycles, then testing and transferring the best — a financially rational strategy rather than a luxury available only to the wealthy.

When Donor Eggs Become Part of the Conversation

For some DOR patients, pursuing donor eggs makes clinical sense — particularly when AMH is extremely low, age is a compounding factor, or previous stimulation cycles have yielded no viable embryos.

This isn't a failure. It's a pragmatic pivot that dramatically changes the success equation. Donor egg IVF success rates are 50–65% per transfer regardless of the recipient's age, because egg quality is determined by the donor's age.

Colombia's donor egg programs typically cost $7,000–$11,000 — compared to $25,000–$40,000 in the US — and offer ethnically diverse donor matching.

Many patients pursue a parallel approach: accumulating their own embryos while simultaneously being matched with a donor, then deciding based on PGT-A results which path offers the best chance.

A Common — and Valid — Approach

Start with 2–3 retrieval cycles using your own eggs. Bank and test embryos. If the results are promising, proceed with your own embryos. If not, transition to donor eggs with the knowledge that you gave your own eggs a genuine chance. Colombia's pricing makes this dual strategy possible for budgets that wouldn't survive a single US cycle.

What to Ask Your Colombian Fertility Specialist

When you consult with a Colombian reproductive endocrinologist about DOR treatment, these questions will help you evaluate their experience:

The Emotional Component

A low AMH diagnosis often comes with grief — the mourning of an assumed biological trajectory. It's important to acknowledge that while also recognizing that low AMH is not a sentence. Patients with AMH levels below 0.5 ng/mL have achieved pregnancies with their own eggs. The path may require more cycles, modified protocols, and patience, but it exists.

What Colombia offers isn't a medical miracle. It's financial access — the ability to pursue multiple cycles, explore modified protocols, and keep donor eggs as a parallel option without the financial devastation that often accompanies fertility treatment in the United States.

Key Takeaway

Low AMH changes your strategy, not your destination. Modified protocols (DuoStim, mini-IVF, natural cycle), embryo accumulation, and parallel donor egg planning are all clinically sound approaches — and Colombia's pricing ($5,000–$8,000 per cycle vs. $15,000–$25,000 in the US) makes the multi-cycle strategy financially viable for patients who would otherwise be limited to a single attempt.

Ready to Explore Your Fertility Options in Colombia?

Connect with top-rated Colombian fertility clinics. Free consultation, no obligation.

Start a Conversation on WhatsApp